The fate of patent stents in patients undergoing coronary artery bypass grafting

dc.authorid0000-0002-6146-2095en_US
dc.authorid0000-0001-5552-3253en_US
dc.authorid0000-0002-3610-3621en_US
dc.contributor.authorBaşgöze, Serdar
dc.contributor.authorŞen, Onur
dc.contributor.authorGüner, Yeşim
dc.contributor.authorDuman, Mert Zihni
dc.contributor.authorKaraçalılar, Mehmet
dc.contributor.authorDemirel, Aylin
dc.contributor.authorBayram, Muhammed
dc.contributor.authorAydın, Ünal
dc.date.accessioned2023-07-07T11:49:36Z
dc.date.available2023-07-07T11:49:36Z
dc.date.issued2023en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kalp ve Damar Cerrahisi Ana Bilim Dalıen_US
dc.description.abstractObjectives: Bypassing a patently stented coronary artery has a risk of flow competition, and leaving it ungrafted has a high risk of stent restenosis. This study determines the fate of patently stented coronary arteries bypassed and left ungrafted. Materials and Methods: Patients undergoing isolated coronary artery bypass grafting (CABG) with previous percutaneous coronary intervention (PCI) were retrospectively scanned between January 1, 2015, and January 1, 2020. Patients undergoing surgery with a patently stented coronary artery were identified. Postoperative coronary angiography was performed in 52 of these patients. Results: There were 24 patients whose patently stented coronary artery was bypassed and 28 whose patently stented coronary artery was not bypassed. The median follow-up time was 49 months in the non-bypass group and 53.5 months in the bypass group. Twenty (71.4%) patently stented coronary arteries remained open in the non-bypass group, and 23 (95.8%) vessels were open in the bypass group (p=0.02). The estimated open rate of vessels was 56% in the non-bypass group and 95% in the bypass group at five years (log-rank p=0.01). Major adverse cardiac events were developed in 12 (42.8%) patients in the non-bypass group and 6 (25%) patients in the bypass group. Conclusion: Patients with an open stented vessel that was not bypassed during CABG have a risk of in-stent restenosis and major adverse cardiac events during the mid-and long-term periods. It may not be safe to leave patently stented coronary arteries ungrafted, particularly those with bare metal stents.en_US
dc.identifier.citationBaşgöze, S., Şen, O., Güner, Y., Duman, M. Z., Karaçalılar, M., Demirel, A. ve diğerleri. (2023). The fate of patent stents in patients undergoing coronary artery bypass grafting. E Journal of Cardiovascular Medicine, 11(2), 60-69.en_US
dc.identifier.doi10.32596/ejcm.galenos.2023.2023-01-03
dc.identifier.endpage69en_US
dc.identifier.issn2147-1924
dc.identifier.issue2en_US
dc.identifier.startpage60en_US
dc.identifier.trdizinid1182817
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1182817
dc.identifier.urihttps://hdl.handle.net/11468/12221
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1182817
dc.identifier.volume11en_US
dc.indekslendigikaynakTR-Dizin
dc.institutionauthorKaraçalılar, Mehmet
dc.language.isoenen_US
dc.publisherGalenos Yayınevien_US
dc.relation.ispartofE Journal of Cardiovascular Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCoronary artery bypass graftingen_US
dc.subjectMajor adverse cardiac eventsen_US
dc.subjectCoronary stent and percutaneous coronary interventionen_US
dc.titleThe fate of patent stents in patients undergoing coronary artery bypass graftingen_US
dc.titleThe fate of patent stents in patients undergoing coronary artery bypass grafting
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
The Fate of Patent Stents in Patients Undergoing Coronary Artery Bypass Grafting.pdf
Boyut:
992.76 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: